문성록 연구실은 방사선종양학을 중심으로 암 환자에서의 방사선치료 및 항암병용치료의 임상 효과를 평가하고, 방사선 손상에 대한 정상조직 회복 기전과 항암제 반응 과정에서의 자가포식·세포사멸 기전을 함께 탐구하는 의학 연구를 수행하며, 치료 성적 향상과 부작용 감소를 위한 중개·임상 연구에 주력하고 있다.
Comparative study on setup accuracy of marker-less surface-guided radiation therapy versus traditional skin marks in hypofractionated whole breast irradiation: A marker-free approach starting from CT simulation
Yuri Jeong, Jung Hoon Kim, Jeong Geun Oh, Kang Kyoo Lee, Sun Rock Moon
Journal of Radiation Research and Applied Sciences
To evaluate the setup accuracy of surface-guided radiation therapy (SGRT) compared with traditional skin marks in patients undergoing hypofractionated whole breast irradiation, with a specific focus on our institution's practice of full eliminating skin marks from the computed tomography (CT) simulation. We retrospectively reviewed 184 breast cancer patients treated with hypofractionated whole breast irradiation between January 2022 and May 2023. Initial patient positioning was performed using either traditional skin marks (n = 93, 1488 sessions) or surface-guidance technology via AlignRT (n = 91, 1456 sessions). The setup accuracy was evaluated by analyzing translational couch shifts in vertical, longitudinal, and lateral directions through daily verification using orthogonal kV images in anterior-posterior and lateral directions obtained after initial positioning. The time from initial patient positioning to treatment was also compared. The average translational couch shifts after initial positioning with skin marks were 3.2 ± 1.8 mm, 3.3 ± 1.5 mm, and 2.8 ± 1.4 mm in the vertical, longitudinal, and lateral directions, respectively. For SGRT, the average translational couch shifts were 3.5 ± 1.5 mm, 3.3 ± 1.4 mm, and 2.8 ± 1.2 mm, respectively. There were no significant differences between SGRT and skin marks in any direction. The average time from initial patient positioning to treatment was shorter in patients with SGRT compared to those with skin marks, 261 s vs. 281 s. The elimination of skin marks from the CT simulation stage, facilitated by SGRT, resulted in comparable setup accuracy with traditional skin marks. In addition, SGRT significantly reduced the time from initial patient positioning to treatment, suggesting that SGRT can be effectively used in hypofractionated whole breast irradiation without the need for skin marks, potentially enhancing patient comfort and convenience.
UNWANTED RADIATION EXPOSURE TO RADIOSENSITIVE ORGANS DURING HAND CT
Dae Jin Nam, Sun Rock Moon, Hong Je Kang
IF 1 (2022)
Radiation Protection Dosimetry
This study aimed to investigate unwanted radiation exposure of radiosensitive organs during computed tomography (CT) scans of the hand. Furthermore, we investigated the effectiveness of a shield in reducing unwanted radiation exposure. In a prospective observational study, the patients were randomized to receive a shield during the hand CT scan. Two group of patients were further randomized to undergo multi-detector CT (MDCT) or cone-beam CT (CBCT). The radiation dose was measured in the target point and the nearest skin surface of radiosensitive organs by attached the thermoluminescent dosemeter chips. When shielding was performed, the radiation doses had decreased significantly with a mean of 79% (65-91%) in the MDCT group and 88.6% (85-93%) in the CBCT group. In the non-shielded group, the radiation doses to the radiosensitive organs decreased inversely with increasing distance, which means that the closer the target point is, the more unwanted radiation exposure increases. It is important to keep radiosensitive organs as far as possible from the target point during CT scan. In particular, it is necessary to shield the radiosensitive organs closer to the target point. Level of Evidence: Level II, Prospective observational study.
Three-dimensional dose reconstruction-based pretreatment dosimetric verification in volumetric modulated arc therapy for prostate cancer
Yuri Jeong, Jeong Geun Oh, Jeong Ku Kang, Sun Rock Moon, Kang Kyoo Lee
Radiation Oncology Journal
The 3%/3 mm criteria were not strict enough to identify any discrepancies between planned and measured doses, and DVH deviations were less than 2% in most parameters. Therefore, gamma criteria of 2%/2 mm and DVH related parameters could be a useful tool for pretreatment verification for VMAT in prostate cancer.